Qorri, B.; Mokhtari, R.B.; Harless, W.W.; Szewczuk, M.R.
Repositioning of Old Drugs for Novel Cancer Therapies: Continuous Therapeutic Perfusion of Aspirin and Oseltamivir Phosphate with Gemcitabine Treatment Disables Tumor Progression, Chemoresistance, and Metastases. Cancers 2022, 14, 3595.
https://doi.org/10.3390/cancers14153595
AMA Style
Qorri B, Mokhtari RB, Harless WW, Szewczuk MR.
Repositioning of Old Drugs for Novel Cancer Therapies: Continuous Therapeutic Perfusion of Aspirin and Oseltamivir Phosphate with Gemcitabine Treatment Disables Tumor Progression, Chemoresistance, and Metastases. Cancers. 2022; 14(15):3595.
https://doi.org/10.3390/cancers14153595
Chicago/Turabian Style
Qorri, Bessi, Reza Bayat Mokhtari, William W. Harless, and Myron R. Szewczuk.
2022. "Repositioning of Old Drugs for Novel Cancer Therapies: Continuous Therapeutic Perfusion of Aspirin and Oseltamivir Phosphate with Gemcitabine Treatment Disables Tumor Progression, Chemoresistance, and Metastases" Cancers 14, no. 15: 3595.
https://doi.org/10.3390/cancers14153595
APA Style
Qorri, B., Mokhtari, R. B., Harless, W. W., & Szewczuk, M. R.
(2022). Repositioning of Old Drugs for Novel Cancer Therapies: Continuous Therapeutic Perfusion of Aspirin and Oseltamivir Phosphate with Gemcitabine Treatment Disables Tumor Progression, Chemoresistance, and Metastases. Cancers, 14(15), 3595.
https://doi.org/10.3390/cancers14153595